Kyprianou P, Betteridge A, Donald A S, Watkins W M
Division of Immunochemical Genetics, MRC Clinical Research Centre, Harrow, Middlesex, U.K.
Glycoconj J. 1990;7(6):573-88. doi: 10.1007/BF01189078.
The alpha-2-L-fucosyltransferase in human plasma has been freed from alpha-3-L-fucosyltransferase activity and purified approximately 200,000-fold by a series of steps involving ammonium sulphate precipitation, hydrophobic chromatography on Phenyl Sepharose 4B and affinity chromatography first on GDP-adipate-Sepharose and then on GDP-hexanolamine-Sepharose. The purified alpha-2-L-fucosyltransferase had a M(r) on gel filtration HPLC of 158,000 and showed optimal activity in the pH range 6.5-7.0. The enzyme transferred fucose equally well to Type 1 (Gal beta 1-3GlcNAc) and Type 2 (Gal beta 1-4GlcNAc) substrates but Type 3 (Gal beta 1-3GalNAc) structures were less efficient acceptors. Competition experiments indicated that a single enzyme species in the purified preparation was responsible for reactivity with the Type 1 and Type 2 structures. Thus the differences in conformation between the Type 1 and Type 2 disaccharides do not appear to influence the capacities of their terminal non-reducing beta-D-galactosyl residues to function as acceptor substrates for the alpha-2-L-fucosyltransferase expressed by the blood group H gene in haemopoietic tissue.
人血浆中的α-2-L-岩藻糖基转移酶已去除α-3-L-岩藻糖基转移酶活性,并通过一系列步骤进行了约200,000倍的纯化,这些步骤包括硫酸铵沉淀、在苯基琼脂糖4B上进行疏水层析以及先后在GDP-己二酸-琼脂糖和GDP-己醇胺-琼脂糖上进行亲和层析。纯化后的α-2-L-岩藻糖基转移酶在凝胶过滤HPLC上的相对分子质量为158,000,在pH 6.5 - 7.0范围内表现出最佳活性。该酶将岩藻糖同等良好地转移至1型(Galβ1-3GlcNAc)和2型(Galβ1-4GlcNAc)底物,但3型(Galβ1-3GalNAc)结构作为受体的效率较低。竞争实验表明,纯化制剂中的单一酶种与1型和2型结构的反应性相关。因此,1型和2型二糖之间的构象差异似乎并不影响其末端非还原β-D-半乳糖基残基作为造血组织中血型H基因表达的α-2-L-岩藻糖基转移酶受体底物的能力。